European healthcare organizations have issued a joint declaration urging regulators to establish one unified approval route for AI-powered medical devices, warning that fragmented oversight could delay patient access to life-saving innovations.
The coalition, which includes clinicians, researchers, and medical technology developers across the continent, points to mounting pressures on health systems. Aging populations, shrinking workforces, and surging demand for services have created an urgent need for tools that can expand diagnostic capacity and streamline care delivery.
AI-enabled diagnostics and medical devices hold particular promise in screening, medical imaging, laboratory testing, and patient monitoring. These systems can spot clinically significant patterns, reduce administrative burden, and help clinicians make faster, better-informed decisions. A European Commission study on AI deployment in healthcare underscores the scale of this potential.
Crucially, the signatories stress that such technologies must perform reliably in real clinical settings. Poorly integrated tools that disrupt workflows will fail regardless of their technical sophistication. Involving clinicians during development and validation, they argue, remains essential for building systems that genuinely assist rather than obstruct.
However, realizing these benefits depends on two factors: public and professional trust, plus regulatory frameworks that balance safety with practicality. The current landscape, according to the organizations, falls short. Multiple overlapping approval processes across European jurisdictions create confusion, slow down market entry, and discourage investment in medical AI innovation.
As a result, the group calls for a single regulatory pathway that would harmonize requirements across EU member states. Such a system, they contend, would maintain rigorous safety standards while giving patients and providers timely access to technologies that could reshape modern medicine.
The full statement, titled “Towards a Single Regulatory Pathway for AI-Enabled Medical Technologies,” outlines specific recommendations for policymakers. European regulators now face mounting pressure to act before the continent falls further behind in the global race to deploy AI in healthcare.
